Preclinical Safety, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Klinisch Patholoog/Hoofd afd. Pathologie Radboud universitair medisch centrum, Nijmegen, the Netherlands.
Toxicol Pathol. 2021 Jun;49(4):711-713. doi: 10.1177/0192623321989644. Epub 2021 Feb 11.
To address the challenges posed by large-scale development, validation, and adoption of artificial intelligence (AI) in pathology, we have constituted a consortium of academics, small enterprises, and pharmaceutical companies and proposed the BIGPICTURE project to the Innovative Medicines Initiative. Our vision is to become the catalyst in the digital transformation of pathology by creating the first European, ethically compliant, and quality-controlled whole slide imaging platform, in which both large-scale data and AI algorithms will exist. Our mission is to develop this platform in a sustainable and inclusive way, by connecting the community of pathologists, researchers, AI developers, patients, and industry parties based on creating value and reciprocity in use based on a community model as the mechanism for ensuring sustainability of the platform.
为了解决人工智能（AI）在病理学方面大规模开发、验证和采用所带来的挑战，我们已经组建了一个由学者、小企业和制药公司组成的联盟，并向创新药物倡议（Innovative Medicines Initiative）提出了 BIGPICTURE 项目。我们的愿景是通过创建第一个符合伦理规范且经过质量控制的全切片成像平台，成为病理学数字化转型的催化剂，在这个平台中，将同时存在大规模数据和人工智能算法。我们的使命是通过基于社区模型的价值创造和互惠使用，以可持续和包容的方式开发这个平台，该模型是确保平台可持续性的机制，将病理学家、研究人员、人工智能开发者、患者和行业各方的社区联系起来。
